Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
The past few years have signaled a major breakthrough on the management of idiopathic pulmonary fibrosis (IPF). Finally, we have drugs in our arsenal able to slow down the inexorable disease natural course. On the other hand, the latter evidence has increased the responsibility for a timely and accu...
Main Authors: | Vasilios Tzilas, Argyris Tzouvelekis, Serafim Chrysikos, Spyridon Papiris, Demosthenes Bouros |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00151/full |
Similar Items
-
Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2020-02-01) -
Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
by: Argyrios Tzouvelekis, et al.
Published: (2017-11-01) -
Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
by: Argyrios Tzouvelekis, et al.
Published: (2018-01-01) -
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01) -
Precision medicine advances in idiopathic pulmonary fibrosis
by: Theodoros Karampitsakos, et al.
Published: (2023-09-01)